El Hospital de Navarra era un centro hospitalario público ubicado en la ciudad de Pamplona. La titularidad y gestión del centro pertenecía al Servicio Navarro de Salud.

During the past decade, Complejo Hospitalario de Navarra conducted 163 clinical trials. In the 10-year time frame, 163 clinical trials started and 37 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 79 clinical trials started and 30 clinical trials were completed. i.e. 38% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario de Navarra" #1 sponsor was "Pfizer" with 11 trials, followed by "Celgene" with 9 trials sponsored, "Fundacion Miguel Servet" with 9 trials sponsored, "PETHEMA Foundation" with 8 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials sponsored. Other sponsors include 148 different institutions and companies that sponsored additional 106 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario de Navarra" #1 collaborator was "Complejo Hospitalario de Navarra" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "Hoffmann-La Roche" with 4 trials as a collaborator and "Pfizer" with 4 trials as a collaborator. Other collaborators include 138 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario de Navarra" are "Multiple Myeloma" (8 trials), "Breast Cancer" (5 trials), "Prostate Cancer" (5 trials), "COVID-19" (4 trials) and "Ulcerative Colitis" (4 trials). Many other conditions were trialed in "Complejo Hospitalario de Navarra" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario de Navarra" are "Drug" (122 trials), "Other" (19 trials), "Biological" (12 trials), "Procedure" (12 trials) and "Device" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Lenalidomide" (6 trials), "Oxaliplatin" (6 trials), "Rituximab" (6 trials) and "Dexamethasone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario de Navarra" are 169 trials for "All" genders, 16 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Complejo Hospitalario de Navarra". 1 are not yet recruiting, 50 are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Complejo Hospitalario de Navarra, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario de Navarra, 6 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 10 trials that are defined as “Not Applicable".